Next, to assess whether BDNF alone allows B-CLL cells to increase NTSR2 and to evade from apoptosis, we co-cultured B-CLL cells with NLC and inhibited each pro-survival cytokine [(using anti-BAFF, -APRIL, and CXCL12 receptor CXCR4 (C-X-C chemokine receptor type 4) antagonist AMD3100], in the presence/absence of an anti-BDNF antibody. The gene discussed is BDNF; the disease is B-cell chronic lymphocytic leukemia.